methacetin-(methoxy-(13)C)
72156-70-8CC(=O)Nc1ccc(O[13CH3])cc1XVAIDCNLVLTVFM-VQEHIDDOSA-NMethacetin-(methoxy-(13)C) is a 13C-modified compound that is methacetin which has 13C as the predominant isotope of the methoxy carbon. In normal subjects, methacetin is rapidly metabolised in the liver, being dealkylated by hepatic CYP1A2 to give paracetamol (acetaminophen); the methyl of the methoxy group is eliminated as CO2. Administering methacetin-(methoxy-13C) to a patient enables the liver (cytochrome P-450 1A2) function to be determined quickly and precisely by measuring the 13CO2 in the breath (e.g. by isotope-selective non-dispersive infrared spectrometry (NDIRS)). It has a role as a diagnostic agent and an isotopic tracer. It is a (13)C-modified compound, a member of acetamides and an aromatic ether.
化学的特性METHACETIN-METHOXY-13C is Crystalline Powder
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory.
V - Various
QV - Various
使用METHACETIN-METHOXY-13C is evaluated in a breath test to predict early liver disfunction due to valproic acid and other cause. Methacetin breath test (MBT) is a rapid, non-invasive assessment of liver function in acute severe liver disease and a potential key tool in future dignosis.
現在のフィルター条件では反応記録がありません。
読み込み中…
72156-70-8DTXSID601298070CHEBI:139355